Atom | In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed)

Funder: National Institutes of Health

Due Dates: June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | October 5, 2025 (New) | November 5, 2025 (Renewal/Resubmission/Revision)

Funding Amounts: Up to $499,999 direct costs per year, for up to 5 years (R01 mechanism; modular or detailed budget as appropriate)

Summary: Supports in-depth phenotyping and research using IMPC-generated knockout mouse strains with embryonic/perinatal lethality or subviability to advance understanding of mammalian gene function and human genetic variation.

Key Information: Clinical trials are not allowed; foreign and domestic applicants are eligible; Data Management and Sharing Plan required.

In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed)

Sign in to see full grant listing